Shrewsbury, MA, United States of America

Adrian Hobson

This inventor holds 22 USPTO granted patents and 16 published patent applications, plus 1 CIPO patent and 4 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Abbvie Inc., Abbvie B.v., Abbott Laboratories Corporation. Active years: 2010-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Adrian Hobson. Retrieved from https://idiyas.com/inventor/adrian-hobson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 22 (Patent Applications = 16)

% Patents Active = 77.3

CIPO Patents = 1 (Patent Applications = 12)

EPO Patents = 4 (Patent Applications = 9)

Average Co-Inventor Count = 7.8

ph-index = 4

Forward Citations = 120(Granted Patents)

Location History:

Shrewsbury, MA (US) (2010 - 2020)
Worcester, MA (US) (2014 - 2022)

Company Filing History:

Abbott Laboratories Corporation

patents

4. 2 out of 6

Abbvie Bahamas Limited

patents

5. 1 out of 52

Abbvie Biotherapeutics Inc.

patents

6. 1 out of 167

Abbvie Deutschland Gmbh and Co Kg

patents

where one patent can have more than one assignee

Years Active: 2010-2024

Loading Chart...

Areas of Expertise:

Anti-CD19 Antibody

Drug Conjugates

Spiro-Cyclic Amines

S1P Modulators

Glucocorticoid Receptor

Immunoconjugates

Fused Heterocyclic Derivatives

Kinase Inhibitors

Chemokine Receptor Antagonists

Sphingosine-1-Phosphate

Oxadiazole Compounds

Rock Activity Modulators

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12121589 - Anti-CD19 antibody drug conjugates (2024-10-22),

2. 11427598 - Spiro-cyclic amine derivatives as S1P modulators (2022-08-30),

3. RE48301 - Fused heterocyclic derivatives as S1P modulators (2020-11-09),

4. 10807991 - Spiro-cyclic amine derivatives as S1P modulators (2020-10-20),

5. 10772970 - Glucocorticoid receptor agonist and immunoconjugates thereof (2020-09-15),

6. 10668167 - Glucocorticoid receptor agonist and immunoconjugates thereof (2020-06-02),

7. 10179791 - Spiro-cyclic amine derivatives as S1P modulators (2019-01-15),

8. 10106501 - Nuclear receptor modulators (2018-10-23),

9. 9951084 - Spiro-cyclic amine derivatives as S1P modulators (2018-04-24),

10. 9670220 - Fused heterocyclic derivatives as S1P modulators (2017-06-06),

11. 9273017 - (Thio)morpholine derivatives as S1P modulators (2016-03-01),

12. 9163007 - 5-substituted indazoles as kinase inhibitors (2015-10-20),

13. 9115151 - Substituted 2,10-dihydro-9-oxa-1,2,4A-triazaphenanthren-3-ones and uses thereof (2015-08-25),

14. 9096612 - Fused heterocyclic derivatives as S1P modulators (2015-08-04),

15. 9045441 - (Thio)morpholine derivatives as S1P modulators (2015-06-02),

Title: Inventor Adrian Hobson: Revolutionizing Technology in Shrewsbury

Introduction: Adrian Hobson, a visionary inventor based in Shrewsbury, MA, is renowned for his groundbreaking contributions to the field of technology.

Latest Patents: Adrian Hobson holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, with his most recent patent focusing on a cutting-edge sustainable energy solution.

Career Highlights: With a career spanning over two decades, Adrian has worked with top research institutions and leading tech companies to develop innovative solutions that have reshaped industries. His work has been recognized with numerous awards and accolades.

Collaborations: Adrian has collaborated with fellow inventors, scientists, and engineers from around the globe, fostering a culture of creativity and innovation. His partnerships have led to the development of revolutionary products that have improved the lives of many.

Conclusion: Adrian Hobson's passion for pushing the boundaries of technology and his relentless pursuit of innovation continue to inspire the next generation of inventors. His impact on the world of technology is truly remarkable.

Profile summary based on public USPTO records.